References
- Costedoat-Chalumeau N, Amoura Z, Villain E, Cohen L, Piette J C. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther 2005; 7: 69–73
- Buyon J P, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee L A, Provost T T, Reichlin M, Rider L, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658–1666
- Eronen M, Siren M K, Ekblad H, Tikanoja T, Julkunen H, Paavilainen T. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000; 106: 86–91
- Jaeggi E T, Hornberger L K, Smallhorn J F, Fouron J L. Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature. Ultrasound Obstet Gynecol 2005; 26: 16–21
- Jenkins K J, Correa A, Feinstein J A, Botto L, Britt A E, Daniels S R, Elixson M, Warnes C A, Webb C L. Noninherited risk factors and congenital cardiovascular defects: current knowledge. A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young. Circulation 2007; 115: 2995–3014
- Roldan C A, Shively B K, Crawford M H. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335: 1424–1430
- Sonesson S E, Salomonsson S, Jacobsson L A, Bremme K, Wahren-Herlenius M. Signs of first degree heart block occur in one third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 2004; 50: 1253–1261
- Friedman D M, Kim M Y, Copel J A, Davis C, Phoon C KL, Glickstein J S, Buyon J P. Utility of cardiac monitoring in fetuses at risk for congenital heart block. Circulation 2008; 117: 485–493
- Mitchell S C, Kornes S B, Berendes H W. Congenital heart disease in 56,109 births. Circulation 1971; 43: 323–332
- Costedoat-Chalumeau N, Amoura Z, Lupoglazoff J M, Thi Huong du L, Denjoy I, Vauthier D, Sebbouh D, Fain O, Georgin-Lavialle S, Ghillani P, et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 2004; 50: 3187–3194
- Meckler K A, Kapur R P. Congenital heart block and associated cardiac pathology in neonatal lupus syndrome. Pediatr Dev Pathol 1998; 1: 136–142
- Galve E, Candell-Riera J, Pigrau C, Permanger-Miralda G, Garcia-Del-Castillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of valvular disease in systemic lupus erythematosus. N Engl J Med 1988; 319: 817–823
- Respondek M L, Kammermeier M, Ludomirsky A, Weil S R, Huhta J C. The prevalence and clinical significance of fetal tricuspid valve regurgitation with normal heart anatomy. Am J Obstet Gynecol 1994; 171: 1265–1270